Detailed taxonomic information on the covered and uncovered OTUs for the BactQuant assay can be found in Additional file 5: Supplemental file 1. Additional file 6: Supplemental file 2. During our in silico validation, a previously published qPCR assay was identified, which was used as a published reference for comparison [15]. The in silico comparison showed that Anlotinib purchase the BactQuant assay covers more OTUs irrespective of the criterion applied (Table2, Figure1, Additional file 2: figure S 1). Based on

the stringent criterion, the published assay has 10 additional uncovered phyla in comparison to BactQuant; these were: Candidate Phylum OP11, Aquificae, Caldiserica, Thermodesulfoacteria, Thermotogae, Dictyoglomi, Deinococcus-Thermus,

Lentisphaerae, Chlamydiae, and Candidate Phylum OP10 (Figure1). Applying the relaxed criterion added two phyla, Aquificae and Lentisphaerae, to those covered by the published assay (Additional file 2: learn more figure S 1). The genus-level coverage of the published assay was also low, with fewer than 50% genus-level coverage in six of its covered phyla. For Cyanobacteria, Planctomycetes, Synergistetes, and Verrucomicrobia, only a single genus was covered by the published assay (Additional file 7: Supplemental file 3). In all, the BactQuant assay covered an additional 288 genera and 16,226 species than the published assay, or the equivalent of 15% more genera, species, and total unique sequences than the published assay (Table2). Detailed taxonomic information on the covered and uncovered OTUs for the published qPCR assay can be found in Additional file 7: Supplemental files 3, Additional file 8: Supplemental files 4. Laboratory analysis of assay performance

using diverse bacterial genomic DNA Laboratory evaluation of the BactQuant assay showed 100% sensitivity against 101 species identified as perfect matches next from the in silico coverage analysis. The laboratory evaluation was performed using genomic DNA from 106 unique species encompassing eight phyla: Actinobacteria (n = 15), Bacteroidetes (n = 2), Deinococcus-Thermus (n = 1), Firmicutes (n = 18), Fusobacteria (n = 1), Proteobacteria (n = 66), Chlamydiae (n = 2), and Spirochaetes (n = 2). Overall, evaluation using genomic DNA from the 101 in silico perfect match species demonstrated r 2 -value of >0.99 and amplification efficiencies of 81 to 120% (Table3). Laboratory evaluation against the five in silico uncovered species showed variable assay amplification profiles and efficiencies. Of these five species, Chlamydia trachomatis, Chlamydophila pneumoniae, and Cellvibrio gilvus were identified as uncovered irrespective of in silico analysis criterion. However, while C. trachomatis and C. DNA Damage inhibitor pneumoniae showed strongly inhibited amplification profile, C. gilvus amplified successfully with a r 2 -value of >0.